Literature DB >> 2466545

Comparison of hemolysins of Vibrio cholerae non-O1 and Vibrio hollisae with thermostable direct hemolysin of Vibrio parahaemolyticus.

M Yoh1, T Honda, T Miwatani.   

Abstract

Hemolysin (Vh-rTDH) produced by Vibrio hollisae and hemolysin (NAG-rTDH) produced by Vibrio cholerae non-O1 were characterized and compared with hemolysin (Vp-TDH) produced by Vibrio parahaemolyticus. These three hemolysins are each composed of two subunits and have similar, but not identical, molecular weights. The amino acid compositions of Vp-TDH and NAG-rTDH are similar, but are different from that of Vh-rTDH. The three hemolysins showed similar lethal toxicities to mice. The effects of temperature on hemolysis and the time dependencies of hemolysis by the three hemolysins were similar. The three were concluded to be immunologically related, but not identical, and to have common and also unique antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2466545     DOI: 10.1139/m88-231

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  3 in total

1.  Development and evaluation of a rapid, simple, and sensitive immunochromatographic assay to detect thermostable direct hemolysin produced by Vibrio parahaemolyticus in enrichment cultures of stool specimens.

Authors:  Kentaro Kawatsu; Masanori Ishibashi; Teizo Tsukamoto
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Purification and characterization of a hemolysin produced by Vibrio mimicus.

Authors:  S Miyoshi; K Sasahara; S Akamatsu; M M Rahman; T Katsu; K Tomochika; S Shinoda
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Association of Vibrio parahaemolyticus thermostable direct hemolysin with lipid rafts is essential for cytotoxicity but not hemolytic activity.

Authors:  Shigeaki Matsuda; Toshio Kodama; Natsumi Okada; Kanna Okayama; Takeshi Honda; Tetsuya Iida
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.